Abstract
Background
Despite the increasing use of breast-conserving therapy, modified radical mastectomy retains an important role in primary as well as in salvage treatment of breast cancer. Nevertheless, a significant number of patients will eventually develop a local recurrence (LR).
Aims
To identify the potential prognostic factors at the time of the first isolated LR, and to compare the expression of several parameters of the molecular biology of breast carcinomas by primary tumors and paired isolated LRs.
Methods
We analyzed the medical records from 1,087 women who underwent mastectomy for breast cancer, out of which 98 developed LRs as the first manifestation of tumor progression. We investigated the prognostic value of various classical prognostic factors, at the time of mastectomy as well as when the diagnosis of LR was made. In addition, by using tissue microarrays and immunohistochemical techniques, we analyzed the expression of estrogen (ER), progesterone (PR) and androgen receptors (AR), ki67, p53, c-erbB-2 and apolipoprotein D in primary tumors and paired isolated LRs from a subset of patients (n = 25).
Results
Patients who developed distant metastases as well as patients with local recurrent disease showed a significantly higher percentage of larger tumors, node-positive status and higher tumoral grade than patients without evidence of tumoral recurrence. Furthermore, patients with LR had a better outcome compared with those with distant metastases, although the former received less frequently adjuvant systemic therapy and/or radiotherapy. Tumor size, histological grade, ER and PR status, and a shorter disease-free interval (<12 months) were significantly associated with overall survival amongst mastectomized patients that developed isolated LR. There was a significant concordance between primary tumors and LRs regarding the expression of the following factors: ER, PR and p53. However, we were not able to demonstrate similar findings for AR, c-erbB-2 and ki67. In addition, ER, PR and p53 status in the LRs were significantly associated with a poorer overall survival.
Conclusions
Based on classical clinicopathological factors as well as on some new biological parameters we have been able to identify subgroups of mastectomized patients with LR differing in their prognosis. Thus, at the present time it would be possible to select group of patients candidates for further and individualized therapeutic strategies.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Halverson KJ, Perez CA, Kuske RR et al (1992) Survival following locoregional recurrence of breast cancer: univariate and multivariate analysis. Int J Radiat Oncol Biol Phys 23:285–291
Bedwinek J (1994) Natural history and management of isolated local-regional recurrence following mastectomy. Semin Radiat Oncol 4:260–269
Kuske RR (1999) Adjuvant irradiation after mastectomy in women with one to three positive axillary nodes: then no; now yes. Semin Radiat Oncol 9:254–258
Recht A, Gray R, Davidson NE et al (1999) Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology Group. J Clin Oncol 17:1689–1700
Fowble B, Gray R, Gilchrist K et al (1988) Identification of a subgroup of patients with breast cancer and histologically positive axillary nodes receiving adjuvant chemotherapy who may benefit from postoperative radiotherapy. J Clin Oncol 6:1107–1117
Pisansky TM, Ingle JN, Schaid DJ et al (1993) Patterns of tumor relapse following mastectomy and adjuvant systemic therapy in patients with axillary lymph node-positive breast cancer. Impact of clinical, histopathologic, and flow cytometric factors. Cancer 72:1247–1260
Pineiro A, Salinas J, Illana J et al (2004) Locoregional recurrence and metastasis in the long-term follow-up of postmastectomy breast cancer patients with T1-T2 tumors and one to three positive lymph nodes. Rev Oncol 6:341– 346
Kamby C, Sengelov L (1999) Survival and pattern of failure following locoregional recurrence of breast cancer. Clin Oncol (R Coll Radiol) 11:156–163
Willner J, Kiricuta IC, Kolbl O (1997) Locoregional recurrence of breast cancer following mastectomy: always a fatal event? Results of univariate and multivariate analysis. Int J Radiat Oncol Biol Phys 37:853–863
Lacour J, Le MG, Hill C et al (1987) Is it useful to remove internal mammary nodes in operable breast cancer? Eur J Surg Oncol 13:309–314
Kaae S, Johansen H (1962) Breast cancer; five year results: two random series of simple mastectomy with postoperative irradiation versus extended radical mastectomy. Am J Roentgenol Radium Ther Nucl Med 87:82–88
Lacour J, Le M, Caceres E et al (1983) Radical mastectomy versus radical mastectomy plus internal mammary dissection. Ten year results of an international cooperative trial in breast cancer. Cancer 51:1941–1943
Alexander JW, Altemeier WA (1964) Susceptibility of injured tissues to hematogenous metastases: an experimental study. Ann Surg 159:933–944
Fisher B, Fisher ER (1959) Experimental studies of factors influencing hepatic metastases. III. Effect of surgical trauma with special reference to liver injury. Ann Surg 150:731–744
Murthy SM, Goldschmidt RA, Rao LN et al (1989) The influence of surgical trauma on experimental metastasis. Cancer 64:2035–2044
Robinson KP, Hoppe E (1962) The development of blood-borne metastases. Effect of local trauma and ischemia. Arch Surg 85:720–724
Skipper D, Jeffrey MJ, Cooper AJ, Alexander P, Taylor I (1989) Enhanced growth of tumour cells in healing colonic anastomoses and laparotomy wounds. Int J Colorectal Dis 4:172–177
Dao TL, Yogo H (1967) Enhancement of pulmonary metastases by x-irradiation in rats bearing mammary cancer. Cancer 20:2020–2025
Fidler IJ, Zeidman I (1972) Enhancement of experimental metastasis by x-ray: a possible mechanism. J Med 3:172–177
Stefanik D, Goldberg R, Byrne P et al (1985) Local-regional failure in patients treated with adjuvant chemotherapy for breast cancer. J Clin Oncol 3:660–665
Sykes HF, Sim DA, Wong CJ, Cassady JR, Salmon SE (1989) Local-regional recurrence in breast cancer after mastectomy and adriamycin-based adjuvant chemotherapy: evaluation of the role of postoperative radiotherapy. Int J Radiat Oncol Biol Phys 16:641–647
Kamby C, Andersen J, Ejlertsen B et al (1991) Pattern of spread and progression in relation to the characteristics of the primary tumour in human breast cancer. Acta Oncol 30:301–308
Crowe JP Jr., Gordon NH, Antunez AR et al (1991) Local-regional breast cancer recurrence following mastectomy. Arch Surg 126:429–432
Berstock DA, Houghton J, Haybittle J, Baum M (1985) The role of radiotherapy following total mastectomy for patients with early breast cancer. World J Surg 9:667–670
van Tienhoven G, Voogd AC, Peterse JL et al (1999) Prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM). EORTC Breast Cancer Cooperative Group and the Danish Breast Cancer Cooperative Group. Eur J Cancer 35:32–38
Dao TL, Nemoto T (1963) The clinical significance of skin recurrence after radical mastectomy in women with cancer of the Breast. Surg Gynecol Obstet 117:447–453
Donegan WL, Perez-Mesa CM, Watson FR (1966) A biostatistical study of locally recurrent breast carcinoma. Surg Gynecol Obstet 122:529–540
Spratt JS (1967) Locally recurrent cancer after radical mastectomy. Cancer 20:1051–1053
Karabali-Dalamaga S, Souhami RL, O’Higgins NJ, Soumilas A, Clark CG (1978) Natural history and prognosis of recurrent breast cancer. Br Med J 2:730–733
Bedwinek JM, Lee J, Fineberg B, Ocwieza M (1981) Prognostic indicators in patients with isolated local-regional recurrence of breast cancer. Cancer 47:2232–2235
Borner M, Bacchi M, Goldhirsch A et al (1994) First isolated locoregional recurrence following mastectomy for breast cancer: results of a phase III multicenter study comparing systemic treatment with observation after excision and radiation. Swiss Group for Clinical Cancer Research. J Clin Oncol 12:2071–2077
Schuck A, Konemann S, Matthees B et al (2002) Radiotherapy in the treatment of locoregional relapses of breast cancer. Br J Radiol 75:663–669
Rimm DL, Camp RL, Charette LA et al (2001) Tissue microarray: a new technology for amplification of tissue resources. Cancer J 7:24–31
Allred DC, Harvey JM, Berardo M, Clark GM (1998) Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 11:155–168
Greco M, Cascinelli N, Galluzzo D et al (1992) Locally recurrent breast cancer after ‘radical’ surgery. Eur J Surg Oncol 18:209–214
Aberizk WJ, Silver B, Henderson IC, Cady B, Harris JR (1986) The use of radiotherapy for treatment of isolated locoregional recurrence of breast carcinoma after mastectomy. Cancer 58:1214–1218
Auchincloss H Jr. (1958) The nature of local recurrence following radical mastectomy. Cancer 11:611–619
Scanlon EF (1985) Local recurrence in the pectoralis muscles following modified radical mastectomy for carcinoma. J Surg Oncol 30:149–151
Toonkel LM, Fix I, Jacobson LH, Wallach CB (1983) The significance of local recurrence of carcinoma of the breast. Int J Radiat Oncol Biol Phys 9:33–39
Crile G Jr. (1972) Low incidence and morbidity of local recurrence after conservative operations for cancer of the breast. Ann Surg 175:249–253
Baral E, Ogenstad S, Wallgren A (1985) The effect of adjuvant radiotherapy on the time of occurrence and prognosis of local recurrence in primary operable breast cancer. Cancer 56:2779–2782
Fisher B, Redmond C, Fisher ER (1980) The contribution of recent NSABP clinical trials of primary breast cancer therapy to an understanding of tumor biology–an overview of findings. Cancer 46:1009–1025
Gilliland MD, Barton RM, Copeland EM 3rd (1983) The implications of local recurrence of breast cancer as the first site of therapeutic failure. Ann Surg 197:284–287
Papaioannou AN (1985) Hypothesis: increasingly intensive locoregional treatment of breast cancer may promote recurrence. J Surg Oncol 30:33–41
Valagussa P, Bonadonna G, Veronesi U (1978) Patterns of relapse and survival following radical mastectomy. Analysis of 716 consecutive patients. Cancer 41:1170–1178
Andry G, Suciu S, Vico P et al (1989) Locoregional recurrences after 649 modified radical mastectomies: incidence and significance. Eur J Surg Oncol 15:476–485
Schwaibold F, Fowble BL, Solin LJ, Schultz DJ, Goodman RL (1991) The results of radiation therapy for isolated local regional recurrence after mastectomy. Int J Radiat Oncol Biol Phys 21:299–310
Hsi RA, Antell A, Schultz DJ, Solin LJ (1998) Radiation therapy for chest wall recurrence of breast cancer after mastectomy in a favorable subgroup of patients. Int J Radiat Oncol Biol Phys 42:495–499
Borner MM, Bacchi M, Castiglione M (1996) Possible deleterious effect of tamoxifen in premenopausal women with locoregional recurrence of breast cancer. Eur J Cancer 32A:2173–2176
Janni W, Shabani N, Dimpfl T et al (2001) Matched pair analysis of survival after chest-wall recurrence compared to mammary recurrence: a long-term follow up. J Cancer Res Clin Oncol 127:455–462
Duffy SW, Tabar L, Fagerberg G et al (1991) Breast screening, prognostic factors and survival–results from the Swedish two county study. Br J Cancer 64:1133–1138
Tabar L, Fagerberg G, Day NE, Duffy SW, Kitchin RM (1992) Breast cancer treatment and natural history: new insights from results of screening. Lancet 339:412–414
Tabar L, Fagerberg G, Duffy SW et al (1992) Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clin North Am 30:187–210
Bloom HJ, Richardson WW (1957) Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 11:359–377
Millis RR, Barnes DM, Lampejo OT, Egan MK, Smith P (1998) Tumour grade does not change between primary and recurrent mammary carcinoma. Eur J Cancer 34:548–553
Cserni G (2002) Tumour histological grade may progress between primary and recurrent invasive mammary carcinoma. J Clin Pathol 55:293–297
Diez-Itza I, Vizoso F, Merino AM et al (1994) Expression and prognostic significance of apolipoprotein D in breast cancer. Am J Pathol 144:310–320
Haffty BG, Hauser A, Choi DH et al (2004) Molecular markers for prognosis after isolated postmastectomy chest wall recurrence. Cancer 100:252–263
Allred DC, Clark GM, Elledge R et al (1993) Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. J Natl Cancer Inst 85:200–206
Elledge RM, Fuqua SA, Clark GM, Pujol P, Allred DC (1993) William L. McGuire Memorial Symposium. The role and prognostic significance of p53 gene alterations in breast cancer. Breast Cancer Res Treat 27:95–102
Kovach JS, Hartmann A, Blaszyk H et al (1996) Mutation detection by highly sensitive methods indicates that p53 gene mutations in breast cancer can have important prognostic value. Proc Natl Acad Sci USA 93:1093–1096
Schmoor C, Sauerbrei W, Bastert G, Schumacher M (2000) Role of isolated locoregional recurrence of breast cancer: results of four prospective studies. J Clin Oncol 18:1696–1708
Zellars RC, Hilsenbeck SG, Clark GM et al (2000) Prognostic value of p53 for local failure in mastectomy-treated breast cancer patients. J Clin Oncol 18:1906–1913
Haylock BJ, Coppin CM, Jackson J, Basco VE, Wilson KS (2000) Locoregional first recurrence after mastectomy: prospective cohort studies with and without immediate chemotherapy. Int J Radiat Oncol Biol Phys 46:355–362
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Carreño, G., del Casar, J.M., Corte, M.D. et al. Local recurrence after mastectomy for breast cancer: analysis of clinicopathological, biological and prognostic characteristics. Breast Cancer Res Treat 102, 61–73 (2007). https://doi.org/10.1007/s10549-006-9310-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-006-9310-0